End-of-day quote
Other stock markets
|
||
- USD | - |
|
07-16 | Aclaris Therapeutics Sells Olumiant Royalties, Milestone Payments From Eli Lilly | MT |
07-05 | Aclaris Therapeutics Insider Bought Shares Worth $405,894, According to a Recent SEC Filing | MT |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapeutics
90.3
%
| 25 | 85.2 % | 28 | 90.3 % | +11.27% |
Contract Research
9.7
%
| 17 | 57.2 % | 3 | 9.7 % | -82.15% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 30 | 100.0 % | 31 | 100.0 % | +5.03% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Neal Walker
CEO | Chief Executive Officer | 54 | 12-06-30 |
Kevin Balthaser
DFI | Director of Finance/CFO | 37 | 16-12-31 |
Ajay Aggarwal
CTO | Chief Tech/Sci/R&D Officer | - | 21-09-30 |
Joseph Monahan
CTO | Chief Tech/Sci/R&D Officer | 69 | 17-07-31 |
General Counsel | - | 18-05-31 | |
James Loerop
PRN | Corporate Officer/Principal | 60 | 22-01-30 |
Elaine Morefield
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Schiff
BRD | Director/Board Member | 58 | 17-08-08 |
Maxine Gowen
BRD | Director/Board Member | 66 | 19-07-01 |
Director/Board Member | 60 | 20-01-06 | |
Director/Board Member | 57 | 16-08-31 | |
Neal Walker
CEO | Chief Executive Officer | 54 | 12-06-30 |
Anand Mehra
BRD | Director/Board Member | 48 | 14-08-31 |
Director/Board Member | 58 | 14-08-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 71,264,786 | 69,445,789 ( 97.45 %) | 0 | 97.45 % |
Company contact information
![address ACLS THER](https://cdn.zonebourse.com/static/address/24220574.png)
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+24.74% | 47.96B | |
-0.47% | 42.45B | |
+43.96% | 41.47B | |
+25.40% | 31.6B | |
+17.96% | 28.63B | |
-4.47% | 28.03B | |
+50.73% | 14.56B | |
+42.56% | 14.14B | |
+1.46% | 12.58B |
- Stock Market
- Equities
- ACRS Stock
- Stock
- Company ACLS THER